Chidamide maintenance therapy in high-risk T-ALL/T-LBL after allo-HSCT: a prospective, single-center, single-arm study.
Guo W, Cao Y, Liu J, Zheng X, Wang M, Zheng Y, Zhang X, Zhai W, Chen X, Zhang R, Ma Q, Yang D, Wei J, He Y, Pang A, Feng S, Han M, Jiang E.
Guo W, et al. Among authors: liu j.
Bone Marrow Transplant. 2023 Oct;58(10):1163-1166. doi: 10.1038/s41409-023-02045-w. Epub 2023 Jul 20.
Bone Marrow Transplant. 2023.
PMID: 37474728
No abstract available.